148 related articles for article (PubMed ID: 12747787)
1. Discovery of a simple picomolar inhibitor of cholesteryl ester transfer protein.
Reinhard EJ; Wang JL; Durley RC; Fobian YM; Grapperhaus ML; Hickory BS; Massa MA; Norton MB; Promo MA; Tollefson MB; Vernier WF; Connolly DT; Witherbee BJ; Melton MA; Regina KJ; Smith ME; Sikorski JA
J Med Chem; 2003 May; 46(11):2152-68. PubMed ID: 12747787
[TBL] [Abstract][Full Text] [Related]
2. Chiral N,N-disubstituted trifluoro-3-amino-2-propanols are potent inhibitors of cholesteryl ester transfer protein.
Durley RC; Grapperhaus ML; Hickory BS; Massa MA; Wang JL; Spangler DP; Mischke DA; Parnas BL; Fobian YM; Rath NP; Honda DD; Zeng M; Connolly DT; Heuvelman DM; Witherbee BJ; Melton MA; Glenn KC; Krul ES; Smith ME; Sikorski JA
J Med Chem; 2002 Aug; 45(18):3891-904. PubMed ID: 12190312
[TBL] [Abstract][Full Text] [Related]
3. Stereospecific inhibition of CETP by chiral N,N-disubstituted trifluoro-3-amino-2-propanols.
Connolly DT; Witherbee BJ; Melton MA; Durley RC; Grapperhaus ML; McKinnis BR; Vernier WF; Babler MA; Shieh JJ; Smith ME; Sikorski JA
Biochemistry; 2000 Nov; 39(45):13870-9. PubMed ID: 11076528
[TBL] [Abstract][Full Text] [Related]
4. Cholesteryl ester transfer protein directly mediates selective uptake of high density lipoprotein cholesteryl esters by the liver.
Gauthier A; Lau P; Zha X; Milne R; McPherson R
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2177-84. PubMed ID: 16123327
[TBL] [Abstract][Full Text] [Related]
5. Novel tetrahydrochinoline derived CETP inhibitors.
Schmeck C; Gielen-Haertwig H; Vakalopoulos A; Bischoff H; Li V; Wirtz G; Weber O
Bioorg Med Chem Lett; 2010 Mar; 20(5):1740-3. PubMed ID: 20137927
[TBL] [Abstract][Full Text] [Related]
6. Effect of inhibiting cholesteryl ester transfer protein on the kinetics of high-density lipoprotein cholesteryl ester transport in plasma: in vivo studies in rabbits.
Kee P; Caiazza D; Rye KA; Barrett PH; Morehouse LA; Barter PJ
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):884-90. PubMed ID: 16373610
[TBL] [Abstract][Full Text] [Related]
7. 2D Quantitative structure-activity relationship studies on a series of cholesteryl ester transfer protein inhibitors.
Castilho MS; Guido RV; Andricopulo AD
Bioorg Med Chem; 2007 Sep; 15(18):6242-52. PubMed ID: 17604633
[TBL] [Abstract][Full Text] [Related]
8. Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib.
Clark RW; Sutfin TA; Ruggeri RB; Willauer AT; Sugarman ED; Magnus-Aryitey G; Cosgrove PG; Sand TM; Wester RT; Williams JA; Perlman ME; Bamberger MJ
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):490-7. PubMed ID: 14739125
[TBL] [Abstract][Full Text] [Related]
9. Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease.
Barter PJ; Kastelein JJ
J Am Coll Cardiol; 2006 Feb; 47(3):492-9. PubMed ID: 16458126
[TBL] [Abstract][Full Text] [Related]
10. Biphenyl-substituted oxazolidinones as cholesteryl ester transfer protein inhibitors: modifications of the oxazolidinone ring leading to the discovery of anacetrapib.
Smith CJ; Ali A; Hammond ML; Li H; Lu Z; Napolitano J; Taylor GE; Thompson CF; Anderson MS; Chen Y; Eveland SS; Guo Q; Hyland SA; Milot DP; Sparrow CP; Wright SD; Cumiskey AM; Latham M; Peterson LB; Rosa R; Pivnichny JV; Tong X; Xu SS; Sinclair PJ
J Med Chem; 2011 Jul; 54(13):4880-95. PubMed ID: 21682257
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice.
Gautier T; Masson D; Jong MC; Pais de Barros JP; Duverneuil L; Le Guern N; Deckert V; Dumont L; Bataille A; Zak Z; Jiang XC; Havekes LM; Lagrost L
Biochem J; 2005 Jan; 385(Pt 1):189-95. PubMed ID: 15339254
[TBL] [Abstract][Full Text] [Related]
12. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits.
Zhang B; Fan P; Shimoji E; Xu H; Takeuchi K; Bian C; Saku K
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1910-5. PubMed ID: 15331428
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of cholesteryl ester transfer protein by cysteine modification.
Connolly DT; Heuvelman D; Glenn K
Biochem Biophys Res Commun; 1996 Jun; 223(1):42-7. PubMed ID: 8660376
[TBL] [Abstract][Full Text] [Related]
15. Modulation of plasma cholesteryl ester transfer protein activity by unsaturated fatty acids in Tunisian type 2 diabetic women.
Smaoui M; Hammami S; Attia N; Chaaba R; Abid N; Kilani N; Kchaou H; Mahjoub S; Abid M; Hammami M
Nutr Metab Cardiovasc Dis; 2006 Jan; 16(1):44-53. PubMed ID: 16399491
[TBL] [Abstract][Full Text] [Related]
16. Dibenzodioxocinones--a new class of CETP inhibitors.
Brückner D; Hafner FT; Li V; Schmeck C; Telser J; Vakalopoulos A; Wirtz G
Bioorg Med Chem Lett; 2005 Aug; 15(15):3611-4. PubMed ID: 15975789
[TBL] [Abstract][Full Text] [Related]
17. Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis.
Klerkx AH; El Harchaoui K; van der Steeg WA; Boekholdt SM; Stroes ES; Kastelein JJ; Kuivenhoven JA
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):706-15. PubMed ID: 16439711
[TBL] [Abstract][Full Text] [Related]
18. Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors.
Eary CT; Jones ZS; Groneberg RD; Burgess LE; Mareska DA; Drew MD; Blake JF; Laird ER; Balachari D; O'Sullivan M; Allen A; Marsh V
Bioorg Med Chem Lett; 2007 May; 17(9):2608-13. PubMed ID: 17331716
[TBL] [Abstract][Full Text] [Related]
19. Discovery of chiral N,N-disubstituted trifluoro-3-amino-2-propanols as potent inhibitors of cholesteryl ester transfer protein.
Durley RC; Grapperhaus ML; Massa MA; Mischke DA; Parnas BL; Fobian YM; Rath NP; Honda DD; Zeng M; Connolly DT; Heuvelman DM; Witherbee BJ; Glenn KC; Krul ES; Smith ME; Sikorski JA
J Med Chem; 2000 Nov; 43(24):4575-8. PubMed ID: 11101348
[No Abstract] [Full Text] [Related]
20. Synthesis and discovery of 2,3-dihydro-3,8-diphenylbenzo[1,4]oxazines as a novel class of potent cholesteryl ester transfer protein inhibitors.
Wang A; Prouty CP; Pelton PD; Yong M; Demarest KT; Murray WV; Kuo GH
Bioorg Med Chem Lett; 2010 Feb; 20(4):1432-5. PubMed ID: 20089400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
